mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.00054 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.01 |